Sema4 is acquiring Opko Health’s subsidiary, GeneDx, in a deal that could have a price tag of $623 million if milestones are added in. The acquisition is set to close in 2Q22.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,